|
|
Deadline: |
April 15, 2015 |
|
April 30, 2015 |
| |
May 8, 2015 |
| |
Extended to May 15, 2015 |
*There will be no more extension.
Please complete your abstract submission and modification
by the above deadline. |
| ◆General Guidelines |
| >> |
Abstracts should be written in English. |
| >> |
Abstract title must be limited to 30 words. |
| >> |
The body of abstracts should contain a maximum of 250 words and must be submitted in English. |
| >> |
All abstracts must be submitted online via this official congress website. Please click on the “Abstract Submission” button below to access the abstract submission form. (Abstract sent by Fax or e-mail will not be accepted.) |
| >> |
Confirmation of your abstract submission will be sent to your registered e-mail address after submission completion. If you do not receive the confirmation, it indicates that your submission was incomplete and you need to contact at the Program Secretariat at prog-
wcmic2015@congre.co.jp |
| >> |
Modifications / cancellation can be made up until the abstract submission deadline,Friday, May 15, 2015. A modification and
cancellation shall not be allowed under any circumstances after the abstract submission deadline. |
| >> |
This abstract submission system works only with the following browsers: Internet Explorer, Firefox, Google Chrome and Safari (ver. 2.0.3 (471.9.2) or later). Please do not use other browsers for abstract submission. |
| Important Points for Abstract Submission |
| |
At the beginning of abstract submission page, please select presentation style.
|
Step 1:Select (1) Symposium * or (2) Satellite Symposium **.
* Hybrid Symposia are included in “Symposium”
** Special Lecture1 and 2 on Sep. 24 are included in “Satellite Symposium”
| (1) |
Symposium (Designated speakers only) |
| (2) |
Satellite Symposium (Designated speakers only) |
| (3) |
Poster (Only for Call for Papers) |
Step 2:Those who select “symposium”, choose your relevant symposium.
SY: Symposium HS: Hybrid Symposium ( ) names of chairs
| SY1 |
Pericytes and microcirculation
(Theodor Burdyga and Claire Peppiatt-Wildman) |
| SY2 |
Endogenous mediators of endothelial barrier stability:
basic mechanisms and implications in human vascular disease and recovery
(Fitz-Roy E. Curry and Rolf Reed) |
| SY3 |
Metabolism and tumor microcirculation/angiogenesis
(Dai Fukumura and Rakesh K. Jain) |
| SY4 |
Recent advances in angiogenesis and lymphangiogenesis
(Yoshiaki Kubota and Nobuyuki Takakura) |
| SY5 |
Structure and function of the endothelial glycocalyx
(Herbert H Lipowsky and Hans Vink) |
| SY6 |
New insights into immune cell regulation in microcirculation
(Mariappan Muthuchamy and Klaus Ley) |
| SY7 |
Impact of mitochondrial function on vascular function and disease
(Ulrich Pohl and John G. McCarron) |
| SY8 |
Microvascular remodeling in the coronary circulation
(Maria Siebes and Fumihiko Kajiya) |
| SY9 |
Recent advances in cerebral microcirculation
(Norio Tanahashi and Jing-Yan Han) |
| SY10 |
The role of EDRF (NO and EDHF), H2S and CO in microcirculation
(Toyotaka Yada and Peter M.Vanhoutte) |
| HS1 |
What can mass spectrometric analysis offer?
-bridge between local metabolism and microvascular functions-
(Per Andrén and Jonathan V. Sweedler) |
| HS2 |
Bone microcirculation: a potential therapeutic target
(Nicola Brown and Ingunn Holen) |
| HS3 |
Metabolics, flowmotion and vascular control
(Axel R Pries and Roland Pittman) |
| HS4 |
Microvascular plasticity and developmental priming: impact on human health
(Geraldine Clough and Giovanni Mann) |
| HS5 |
Inflammation, oxidative stress and microRNAs in vascularisation
(Jozef Dulak and Ed van Bavel) |
| HS6 |
TRP channels and vascular disease
(Scott Earley and Mark T. Nelson) |
| HS7 |
Myeloid cell trafficking in disease
(Catherine C. Hedrick and Paul Kubes) |
| HS8 |
Microvascular plasticity in health and disease.
(Jay Hoying and Mark Olfert) |
| HS9 |
Mechanobiology: roles of cellular and non-cellular elements
(Gerald Meininger and
Mike Hill) |
| HS10 |
Building vascular networks: determination, randomness and functional control
(Axel R Pries and Peter Carmeliet) |
| HS11 |
Platelets: key mediators of inflammation in the microcirculation
(Rolando E. Rumbaut and Meinrad Gawaz) |
| HS12 |
Disease intervention: targeting the microcirculation
(Marianne Tare and Laura Parry) |
Step 3: Those who select “Satellite Symposium”, choose your relevant symposium.
SS: Satellite Symposium ( ) names of chairs
| SS1 |
A key cardiovascular signaling molecule in cardiovascular disease |
| SS2 |
Molecular Mechanisms in Lymphatic Function & Lymphangiogenesis |
| SS3 |
Cutting edge of ocular microcirculation research |
| SS4 |
The mechanosensor for shear stress and its role on the cerebral aneurysm formation; from the basic science to clinical research |
| SS5 |
Mechanisms of microvascular dysfunction under disease conditions and therapeutic developments |
| SS6 |
Inflammatory mechanism and functional remodeling in microvascular diseases |
| SS7 |
New aspects in interrelations between microlympho- and microhemovasculature; Relevance to fluid retention mechanism |
| SS8 |
Activate blood and remove stasis
(Jing-Yan Han and Makoto to Suematsu) |
| SS9 |
Qi drive blood
(Greet Schmid-Schonbein and Jing-yan Han) |
| SS10 |
Qi retaining body fluid and blood
(Qiao-Bin Huangand Jerome W. Breslin) |
| SS11 |
Special Lecture1 (Dr. Shimokawa) |
| SS12 |
Special Lecture2 (Dr. Shimokawa and Dr.Vanhoutte) |
| ◆ID and Password |
| ・ |
After registering your abstract, you will receive a confirmation by e-mail with your login ID and password codes. |
| ・ |
We cannot inform you of your password and ID for security reasons. Please print out the website after your registration. |
| ・ |
If you wish to make any corrections to your abstract already submitted or wish to delete it, Click “Modification” button and use your personal ID and password. |
| ◆Attention |
| ・ |
The first author or presenter must make a pre-registration when submitting an abstract. |
| ・ |
The first author must be corresponding author. Maximum 20 co-author’s names can be included, and will appear on the printed materials in the submitted order. |
| ・ |
The first author or presenter who cannot make a pre-registration due to some unavoidable reasons must inform the secretariat in advance. |
| ・ |
This abstract submission system works only with the following browsers: Internet Explorer, Firefox, Google Chrome and Safari (ver. 2.0.3 (471.9.2) or later). Please do not use other browsers for abstract submission. |
| ・ |
The first author is responsible for getting agreements from co-authors before submission. |
| ・ |
After the submission period, change of abstract and addition and/or change of authors cannot be made. Please make sure all authors are entered. |
| ・ |
Any submitted abstracts will not be edited or proof-read before printing. The first author is responsible for his/her abstract. |
| ◆CORRESPONDENCE |
Program Secretariat of 10th World Congress for Microcirculation (WCMic 2015)
c/o Congress Corporation,
Kohsai-kaikan Bldg., 5-1 Kojimachi, Chiyoda-ku, Tokyo 102-8481, Japan
Phone: +81-3-5216-5318 Fax: +81-3-5216-5552
E-mail:prog-wcmic2015@congre.co.jp |
 |